Aerie Pharmaceuticals, Inc. Operating Lease, Liability, Noncurrent
Aerie Pharmaceuticals, Inc. had Operating Lease, Liability, Noncurrent of $19.52 million as of 2022-09-30, per its 10-Q filed 2022-11-04.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2022-11-04
- 2022-09-30: Operating Lease, Liability, Noncurrent $19.52M.
- 2022-06-30: Operating Lease, Liability, Noncurrent $20.42M.
- 2022-03-31: Operating Lease, Liability, Noncurrent $21.03M.
- 2021-12-31: Operating Lease, Liability, Noncurrent $21.75M.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2022-09-30 | $19.52M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $20.42M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $21.03M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $21.75M 10-Q · filed 2022-11-04 |
| 2021-09-30 | $22.50M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $10.03M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $9.91M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $10.21M 10-K · filed 2022-02-25 |
| 2020-09-30 | $10.76M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $10.50M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $10.83M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $12.10M 10-K · filed 2021-02-26 |
| 2019-09-30 | $12.23M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $13.24M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $12.04M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $0.00 10-Q · filed 2019-11-07 |